This study is not accepting new patients
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study started
- Principal Investigator
- by Thomas Hope, MD
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Thomas Hope, MD
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He is also the Associate Chair for Business Strategy for Radiology. He serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- University of California, San Francisco
- ID
- NCT04377152
- Study Type
- Expanded Access
- Last Updated